Your session is about to expire
← Back to Search
Photobiomodulation Therapy for Stress Fractures (PM12 Trial)
N/A
Recruiting
Led By Daniel Rhon, DSc, PhD
Research Sponsored by Brooke Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly up to 6 weeks, 4 months
Summary
This trial is testing a light therapy called PBMT to help military trainees with leg or foot stress fractures heal faster. The therapy aims to reduce pain and inflammation, helping cells repair more quickly. The goal is to see if this treatment helps trainees return to duty sooner. Photobiomodulation therapy (PBMT) combines low-level laser therapy (LLLT) and light emitting diode therapy (LEDT) to enhance cellular repair and reduce inflammation.
Who is the study for?
This trial is for military trainees aged 17-64 at Fort Sam Houston with a confirmed diagnosis of tibial or metatarsal stress injuries. They must understand English and commit to the study for up to 6 weeks, with follow-up through 4 months. Exclusions include recent dry needling, certain medical conditions like neuropathy, albinism, heart pacemakers, tattoos in treatment area, pregnancy plans during the study period, severe non-union fractures, light-induced allergies or eczema.
What is being tested?
The trial tests photobiomodulation therapy (PBMT) alongside standard physical therapy for bone stress injuries versus a sham PBMT with standard care. Participants are randomly assigned to either active or placebo treatments and evaluated on recovery speed and improvements in pain and function.
What are the potential side effects?
While specific side effects of PBMT aren't detailed here, common concerns may include skin irritation at the treatment site or discomfort during therapy sessions. The safety profile will be closely monitored given that participants have various exclusions related to sensitivity towards light-based therapies.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weekly up to 6 weeks, 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly up to 6 weeks, 4 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Time to Return to Duty
Secondary study objectives
Defense and Veteran's Pain Rating Scale (DVPRS) with supplemental questions
Hopping Test
Lower Extremity Functional Scale (LEFS)
+1 moreOther study objectives
Fredericson grading system
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Standard Physical Therapy and Photobiomodulation TherapyExperimental Treatment1 Intervention
61 Participants will be randomized to this group and will receive Photobiomodulation Therapy (PBMT) in addition to standard physical therapy.
Group II: Standard Physical Therapy and Sham Photobiomodulation TherapyPlacebo Group1 Intervention
61 Participants will be randomized to this group and will receive sham Photobiomodulation Therapy (PBMT) in addition to standard physical therapy.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Photobiomodulation Therapy (PBMT) is a treatment that uses low-level lasers or LEDs to promote tissue repair and reduce inflammation in Metatarsal Stress Fracture patients. The light energy penetrates the skin and is absorbed by the cells, enhancing cellular function and promoting healing.
This can reduce pain, decrease inflammation, and accelerate tissue repair, which is crucial for patients as it can potentially shorten recovery time and improve functional outcomes.
Effect of cortisone and an anabolic steroid upon plasma hydroxyproline during fracture healing in rabbits.Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossification.[Extracorporeal shockwave therapy (ESWT) in orthopedic indications: a selective review].
Effect of cortisone and an anabolic steroid upon plasma hydroxyproline during fracture healing in rabbits.Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossification.[Extracorporeal shockwave therapy (ESWT) in orthopedic indications: a selective review].
Find a Location
Who is running the clinical trial?
Uniformed Services University of the Health SciencesFED
124 Previous Clinical Trials
90,554 Total Patients Enrolled
Brooke Army Medical CenterLead Sponsor
129 Previous Clinical Trials
27,515 Total Patients Enrolled
The Geneva FoundationOTHER
37 Previous Clinical Trials
13,529 Total Patients Enrolled
Daniel Rhon, DSc, PhDPrincipal InvestigatorUniformed Services University of the Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a stress fracture in my tibia that is not on the inner side.My bone fracture has not healed and is considered severe.I experience ongoing or frequent pain, numbness, or tingling in my leg below the knee.I have used Depo Provera in the last 2 years.I have a tattoo in the area where I will receive light-based therapy.I have not had PRP, corticosteroid injections, or prolotherapy in the last 3 months.I have a diagnosed stress fracture in my foot or shin confirmed by imaging.I have been using anti-inflammatory steroids in the last two weeks.I have been diagnosed with an autoimmune disease.I am currently in a study for a specific bone injury treatment.I am between 17 and 64 years old.I have been diagnosed with an eating disorder in the past or currently.I have a light-induced allergy or photosensitive eczema.I have not had a menstrual period for 6 months or more, or I have had only 4-9 periods in the last year.I haven't taken any medications that make me sensitive to light or heat in the last 5 days.I have been diagnosed with neuropathy that affects my ability to feel pain.I have had dry needling therapy in the last 4 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Standard Physical Therapy and Sham Photobiomodulation Therapy
- Group 2: Standard Physical Therapy and Photobiomodulation Therapy
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.